Clinical trial
A Phase 2 Randomized Placebo-Controlled Trial of Levodopa in Angelman Syndrome
NCT01281475 is registered in ClinicalTrials.gov with Wen-Hann Tan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Randomized Placebo-Controlled Trial of Levodopa in Angelman Syndrome
- Lead sponsor
- Wen-Hann Tan
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- January 31, 2011
- Completion date
- July 31, 2015
- Enrollment
- 67 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.